Public Market Listing
300558SZSE ChiNext
Live quotes, historical charts, and market capitalization for Betta Pharmaceuticals Co. are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(7 total)
7Total Assets
0Approved
3Phase 3 / Filed
4Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | EGFRSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 3 | CDK4 and CDK6Small molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 3 | EGFRSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 1/2 | EGFRSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 1/2 | RAS (pan-RAS, RAS-mutant tumors)Small molecule | Non-Small Cell Lung Cancer | |
| Phase 1 | PD-L1Small molecule | Non-Small Cell Lung Cancer | |
| Phase 1 | EGFR L858R (including T790M/C797S resistant mutants)Small molecule | Non-Small Cell Lung Cancer |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.